APA (7th ed.) Citation

Gahlawat, A. W., Witte, T., Sinn, P., & Schott, S. (2023). Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer. Scientific Reports, 13(1), 1. https://doi.org/10.1038/s41598-023-32243-x

Chicago Style (17th ed.) Citation

Gahlawat, Aoife Ward, Tania Witte, Peter Sinn, and Sarah Schott. "Circulating Cf-miRNA as a More Appropriate Surrogate Liquid Biopsy Marker than CfDNA for Ovarian Cancer." Scientific Reports 13, no. 1 (2023): 1. https://doi.org/10.1038/s41598-023-32243-x.

MLA (9th ed.) Citation

Gahlawat, Aoife Ward, et al. "Circulating Cf-miRNA as a More Appropriate Surrogate Liquid Biopsy Marker than CfDNA for Ovarian Cancer." Scientific Reports, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1038/s41598-023-32243-x.